Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Role of thymic B cells in immune tolerance

Award Number: K99AI184587
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 07/12/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2026

Group Awards By:

View Award Description

Role of thymic B cells in immune tolerance - Project Summary/Abstract Generation of a functional adaptive immune response relies on the collaboration of the cellular (T cell) and humoral (B cell) compartments. T follicular helper (Tfh) cells provide essential help to B cells to undergo isotype class-switch recombination and generate high-affinity antibody through somatic hypermutation. Follicular regulatory T (Tfr) cells have been implicated in controlling this process as they have been shown to be critical in regulating germinal center B cell responses and prevent autoantibody formation. However, how these Tfr cells develop is unknown. B cells undergo a unique type-III interferon dependent and isotype class- switching process in the thymus, the location of T cell development, and induce clonal deletion and Treg cell selection. Developing Treg cells that depend on licensed thymic B cell antigens may also interact with activated B cells in the periphery and take on a Tfr phenotype. Thus, Treg cells selected by thymic B cells may become Tfr cells in the periphery and help to reduce the risk autoantibody generation. The objective of this work is to understand what role licensed thymic B cells play in T cell tolerance. In this proposal we identified T cell receptors that generate Tfr cells when expressed by developing T cells, propose to study the requirements of these TCRS for selection as well as explore further functional consequences when thymic B cells are absent. Our central hypothesis is that type-III interferon drives thymic B cell licensing, resulting in the presentation of B cell activation induced self-peptides, thereby supporting the development of Treg cells that become Tfr cells and regulate humoral immune responses. Through this work we hope to generate a mechanistic understanding of the impact of thymic B cell activation on immune tolerance. These findings will have the potential to reveal new pathways regulating adaptive immune responses and have implications in our understanding of autoimmune diseases like systemic lupus erythematous or rheumatoid arthritis, diseases where pathogenic autoreactive antibodies mediate disease. I am applying for this K99/R00 as an Instructor in Laboratory Medicine and Pathology Department with subspecialty training in Molecular Pathology. My long-term career goals are to support for the clinical diagnosis of autoimmunity and inborn errors of immunity and to lead an R01 funded research program that investigates central tolerance and immunodeficiency.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2027 ( Subtotal = $0 )
2027	2025	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Allergy and Infectious Diseases Research	000	2	10/9/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $138,051 )
2025	2025	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Allergy and Infectious Diseases Research	000	2	7/8/2025	NON-COMPETING CONTINUATION	$138,051
														Subtotal = $138,051

Issue Date FY: 2024 ( Subtotal = $138,051 )
2024	2024	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Allergy and Infectious Diseases Research	000	1	7/12/2024	NEW	$138,051
														Subtotal = $138,051

Grand Total All Awards = $276,102

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Role of thymic B cells in immune tolerance

Award Number: K99AI184587

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 07/12/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer